The Food and Drug Administration reportedly adds warning labels to the Johnson & Johnson COVID-19 vaccine amid reports of 100 cases of Guillain-Barré syndrome.

According to NBC News, ninety-five of those cases required hospitalization, with one person dying. In a statement issued on Monday, the FDA detailed how Guillain-Barré syndrome damages nerve cells and can cause muscle weakness. In extremely rare cases, it can cause paralysis.